Tibsovo Interactions
There are 583 drugs known to interact with Tibsovo (ivosidenib), along with 2 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 252 are major, 313 are moderate, and 18 are minor.
- View all 583 medications that may interact with Tibsovo
- View Tibsovo alcohol/food interactions (2)
- View Tibsovo disease interactions (2)
Most frequently checked interactions
View interaction reports for Tibsovo (ivosidenib) and the medicines listed below.
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Advate (antihemophilic factor)
- Alimta (pemetrexed)
- amitriptyline
- Aubagio (teriflunomide)
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Braftovi (encorafenib)
- Brineura (cerliponase alfa)
- Caprelsa (vandetanib)
- clonazepam
- clonidine
- Cosentyx (secukinumab)
- Crestor (rosuvastatin)
- Crixivan (indinavir)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Humira (adalimumab)
- Kalydeco (ivacaftor)
- losartan
- Lyrica (pregabalin)
- magnesium oxide
- Ozempic (semaglutide)
- Retrovir (zidovudine)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tegretol (carbamazepine)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
Tibsovo alcohol/food interactions
There are 2 alcohol/food interactions with Tibsovo (ivosidenib).
Tibsovo disease interactions
There are 2 disease interactions with Tibsovo (ivosidenib) which include:
Report options
More about Tibsovo (ivosidenib)
- Tibsovo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Ziihera
Ziihera (zanidatamab) is a bispecific HER2-directed antibody used to treat HER2-positive biliary ...
Pemazyre
Pemazyre is used to treat certain types of bile duct cancer and myeloid/lymphoid neoplasms ...
Lytgobi
Lytgobi (futibatinib) is used for the treatment of bile duct cancer (intrahepatic ...
Pemigatinib
Pemigatinib is used for cholangiocarcinoma, myeloid/lymphoid neoplasms
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
